A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects

Title
A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects
Authors
Keywords
Cardiometabolic risk, Epicatechin, Metabolic syndrome, Nutraceutics, Plasma triglycerides, Triglyceride-HDL ratio
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 223, Issue -, Pages 500-506
Publisher
Elsevier BV
Online
2016-08-09
DOI
10.1016/j.ijcard.2016.08.158

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now